Limited Engagement in Cancer Screening Initiatives in India: A Comprehensive Review of Breast and Cervical Cancer Programs - Report - MDSpire

Limited Engagement in Cancer Screening Initiatives in India: A Comprehensive Review of Breast and Cervical Cancer Programs

  • By

  • Jubina Balan Venghateri

  • Priyansh Nathani

  • Shreya Goyal

  • Bhakti Sarang

  • Harshal Rawtani

  • Priti Patil

  • Deepa KV

  • Nethra Jain

  • Anita Gadgil

  • Nobhojit Roy

  • November 7, 2025

  • 0 min

Share

Clinical Report: Limited Engagement in Cancer Screening Initiatives in India

Overview

This comprehensive review highlights the low participation rates in breast and cervical cancer screening programs in India, despite the significant burden of these cancers. It underscores the need for improved outreach and infrastructure to enhance early detection and treatment.

Background

Breast and cervical cancers account for nearly 39% of all cancers among women in India, with significant mortality rates due to late-stage diagnoses. Despite the launch of a national screening program in 2016, participation remains critically low, with less than 2% of women undergoing screening. Understanding the barriers to screening is essential for developing effective public health strategies.

Data Highlights

No numerical data available in the article.

Key Findings

  • Breast and cervical cancers are the leading cancers among Indian women, with high incidence and mortality rates.
  • Less than 2% of women in India have participated in cervical and breast cancer screening programs.
  • Screening programs are primarily opportunistic, leading to late-stage cancer diagnoses.
  • Factors contributing to low screening uptake include lack of awareness, limited access to services, and inadequate infrastructure.
  • The national screening program launched in 2016 has not significantly improved participation rates.

Clinical Implications

Healthcare professionals should prioritize awareness campaigns and improve access to screening services to enhance participation rates. Addressing barriers such as education and infrastructure is crucial for effective cancer prevention strategies.

Conclusion

Reiterate the importance of addressing specific barriers identified in the background.

References

  1. GLOBOCAN 2020, International Agency for Research on Cancer, 2020 -- Cancer Incidence and Mortality in India
  2. WHO, 2021 -- New recommendations for screening and treatment to prevent cervical cancer
  3. Are Breast Cancer Characteristics Consistent Across Asian and Western Populations?
  4. European Radiology — Key Guidelines for Breast Cancer Screening: Recommendations from EUSOBI
  5. asco ai in oncology — AI-Enabled Platform Improves Cancer Prevention Access in Unaffected Individuals
  6. The ASCO Post — Actively Recruiting Clinical Trials Focused on Cancer Prevention
  7. GLOBOCAN 2022 - India Fact Sheet
  8. AI-Enabled Platform Improves Cancer Prevention Access
  9. New recommendations for screening and treatment to prevent cervical cancer
  10. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai | The BMJ

Original Source(s)

Related Content